{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:50:54Z","timestamp":1767073854012,"version":"3.48.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-20-279"],"award-info":[{"award-number":["OFIL-20-279"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Globally, evidence indicates that most people prefer to receive care and die at home, provided high-quality care is available. However, systemic and logistical challenges often prevent this outcome. Palliate is a nurse-led intervention aiming to address these barriers, supporting lay-carers in administering end-of-life subcutaneous medications to their loved ones, through training, written guidance, and documentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To explore the perceptions and experiences of patients, carers, and healthcare professionals regarding the acceptability of the Palliate intervention, using the Theoretical Framework of Acceptability (TFA), including perceived barriers and opportunities to its implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A qualitative study was conducted using semi-structured interviews with healthcare professionals, patients, carers, and policy-makers, informed by the TFA. Data were analysed thematically using deductive analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty participants, including people with a diagnosis of advanced illness, carers, and a range of healthcare professionals involved in end-of-life care, provided perspectives on the acceptability of the intervention in end-of-life care. Participants described potential benefits, including improved symptom management, reduced waiting times for medication, and increased empowerment for families to support care at home. Concerns were raised about carer burden, emotional responsibility, and the need for professional oversight. Some participants spoke from direct experience of administering or supporting the intervention in practice, providing insights into both its practical value and the challenges of implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While the Palliate intervention was generally viewed as acceptable and potentially beneficial, its broader implementation requires careful consideration. Its acceptability was conditional on carers receiving clear training, ongoing professional support, and being able to participate voluntarily. These findings offer new insights into the boundaries of lay caregiving and have implications for the implementation of family-administered end-of-life care within health systems. Further research is needed to evaluate its safety, impact, and feasibility in diverse contexts before wider adoption can be recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12904-025-01942-9","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:14:54Z","timestamp":1763979294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acceptability of supporting lay-carer administration of anticipatory subcutaneous medications at home: a qualitative study using the theoretical framework of acceptability"],"prefix":"10.1186","volume":"24","author":[{"given":"David","family":"Sunkersing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calandra","family":"Feather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivor","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imogen","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Droney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryony Dean","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bee","family":"Wee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ara","family":"Darzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Grailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"1942_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12904-021-00802-6\/TABLES\/1","volume":"20","author":"KE Sleeman","year":"2021","unstructured":"Sleeman KE, Timms A, Gillam J, Anderson JE, Harding R, Sampson EL, et al. Priorities and opportunities for palliative and end of life care in united Kingdom health policies: a National documentary analysis. BMC Palliat Care. 2021;20:1\u201310. https:\/\/doi.org\/10.1186\/S12904-021-00802-6\/TABLES\/1.","journal-title":"BMC Palliat Care"},{"key":"1942_CR2","unstructured":"Department of Health & Social Care. The Government\u2019s revised mandate to NHS England for 2018-19 2019. https:\/\/assets.publishing.service.gov.uk\/media\/5ce3cf9840f0b627e6e7b194\/revised-mandate-to-nhs-england-2018-to-2019.pdf (accessed May 6, 2025)."},{"key":"1942_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/07481187.2023.2225042","volume":"48","author":"K Pollock","year":"2024","unstructured":"Pollock K, Caswell G, Turner N, Wilson E. The ideal and the real: patient and bereaved family caregiver perspectives on the significance of place of death. Death Stud. 2024;48:312\u201325. https:\/\/doi.org\/10.1080\/07481187.2023.2225042.","journal-title":"Death Stud"},{"key":"1942_CR4","doi-asserted-by":"publisher","unstructured":"Shepperd S, Gon\u00e7alves-Bradley DC, Straus SE, Wee B. Hospital at home: home-based end-of-life care. Cochrane Database Syst Rev. 2021;3. https:\/\/doi.org\/10.1002\/14651858.CD009231.PUB3.","DOI":"10.1002\/14651858.CD009231.PUB3"},{"key":"1942_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12904-022-00939-Y\/FIGURES\/1","volume":"21","author":"TM Nys\u00e6ter","year":"2022","unstructured":"Nys\u00e6ter TM, Olsson C, Sandsdalen T, Wilde-Larsson B, Hov R, Larsson M. Preferences for home care to enable home death among adult patients with cancer in late palliative phase \u2013 a grounded theory study. BMC Palliat Care. 2022;21:1\u201310. https:\/\/doi.org\/10.1186\/S12904-022-00939-Y\/FIGURES\/1.","journal-title":"BMC Palliat Care"},{"key":"1942_CR6","unstructured":"NHS England. NHS plan to cut avoidable admissions to further boost efforts to reduce waiting times 2024. https:\/\/www.england.nhs.uk\/2024\/05\/nhs-plan-to-cut-avoidable-admissions-to-further-boost-efforts-to-reduce-waiting-times\/ (accessed May 12, 2025)."},{"key":"1942_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1472-684X-12-9","volume":"12","author":"M Gott","year":"2013","unstructured":"Gott M, Gardiner C, Ingleton C, Cobb M, Noble B, Bennett MI, et al. What is the extent of potentially avoidable admissions amongst hospital inpatients with palliative care needs? BMC Palliat Care. 2013;12:9. https:\/\/doi.org\/10.1186\/1472-684X-12-9.","journal-title":"BMC Palliat Care"},{"key":"1942_CR8","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.3399\/BJGP19X704561","volume":"69","author":"S Hoare","year":"2019","unstructured":"Hoare S, Kelly MP, Barclay S. Home care and end-of-life hospital admissions: a retrospective interview study in english primary and secondary care. Br J Gen Pract. 2019;69:e561\u20139. https:\/\/doi.org\/10.3399\/BJGP19X704561.","journal-title":"Br J Gen Pract"},{"key":"1942_CR9","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1016\/J.JPAINSYMMAN.2024.01.014","volume":"67","author":"S Pinto","year":"2024","unstructured":"Pinto S, Lopes S, de Sousa AB, Delalibera M, Gomes B. Patient and family preferences about place of End-of-Life care and death: an umbrella review. J Pain Symptom Manage. 2024;67:e439\u201352. https:\/\/doi.org\/10.1016\/J.JPAINSYMMAN.2024.01.014.","journal-title":"J Pain Symptom Manage"},{"key":"1942_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/S12904-016-0077-8","author":"V Costa","year":"2016","unstructured":"Costa V, Earle CC, Esplen MJ, Fowler R, Goldman R, Grossman D, et al. The determinants of home and nursing home death: a systematic review and meta-analysis. BMC Palliat Care. 2016. https:\/\/doi.org\/10.1186\/S12904-016-0077-8.","journal-title":"BMC Palliat Care"},{"key":"1942_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/J.JPAINSYMMAN.2019.12.370","volume":"60","author":"EE Johnston","year":"2020","unstructured":"Johnston EE, Martinez I, Currie E, Brock KE, Wolfe J. Hospital or home? Where should children die and how do we make that a reality? J Pain Symptom Manage. 2020;60:106\u201315. https:\/\/doi.org\/10.1016\/J.JPAINSYMMAN.2019.12.370.","journal-title":"J Pain Symptom Manage"},{"key":"1942_CR12","unstructured":"Macmillan Cancer Support. The Final Injustice: Variation in end of life care in England. 2017. https:\/\/www.macmillan.org.uk\/_images\/MAC16904-end-of-life-policy-report_tcm9-321025.pdf. (accessed November, 11, 2025)."},{"key":"1942_CR13","unstructured":"Davidson S, Gentry T. Age UK End of Life Evidence Review. 2013. https:\/\/www.ageuk.org.uk\/siteassets\/documents\/reports-and-publications\/reports-and-briefings\/health--wellbeing\/rb_oct13_age_uk_end_of_life_evidence_review.pdf. (accessed November 11, 2025)."},{"key":"1942_CR14","unstructured":"Nuffield Trust. Public expenditure in the last year of life n.d. https:\/\/www.nuffieldtrust.org.uk\/research\/public-expenditure-in-the-last-year-of-life (accessed July 20, 2025)."},{"key":"1942_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/PME.12464","volume":"15","author":"MG Kestenbaum","year":"2014","unstructured":"Kestenbaum MG, Vilches AO, Messersmith S, Connor SR, Fine PG, Murphy B, et al. Alternative routes to oral opioid administration in palliative care: a review and clinical summary. Pain Med. 2014;15:1129\u201353. https:\/\/doi.org\/10.1111\/PME.12464.","journal-title":"Pain Med"},{"key":"1942_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/S11096-015-0094-3","volume":"37","author":"AD Masman","year":"2015","unstructured":"Masman AD, van Dijk M, Tibboel D, Baar FPM, Math\u00f4t RAA. Medication use during end-of-life care in a palliative care centre. Int J Clin Pharm. 2015;37:767. https:\/\/doi.org\/10.1007\/S11096-015-0094-3.","journal-title":"Int J Clin Pharm"},{"key":"1942_CR17","doi-asserted-by":"publisher","DOI":"10.3310\/HTA24250","volume":"24","author":"M Poolman","year":"2020","unstructured":"Poolman M, Roberts J, Wright S, Hendry A, Goulden N, Holmes EAF, et al. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT. Health Technol Assess. 2020;24:1. https:\/\/doi.org\/10.3310\/HTA24250.","journal-title":"Health Technol Assess"},{"key":"1942_CR18","unstructured":"First Community Health & Care. Administering injectable medication n.d. https:\/\/www.firstcommunityhealthcare.co.uk\/administering-injectable-medication-information-for-patients-families-and-friends\/ (accessed July 22, 2025)."},{"key":"1942_CR19","doi-asserted-by":"publisher","first-page":"1488688","DOI":"10.3389\/FSOC.2024.1488688\/BIBTEX","volume":"9","author":"G Hodge","year":"2024","unstructured":"Hodge G, Kallis G, Oh TM, Wheat H, Pearce S. Exploring perceived barriers to palliative and end of life care provision in South-West england: bringing together the perspectives of professionals, patients, and families. Front Sociol. 2024;9:1488688. https:\/\/doi.org\/10.3389\/FSOC.2024.1488688\/BIBTEX.","journal-title":"Front Sociol"},{"key":"1942_CR20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1089\/JPM.2022.0555","volume":"26","author":"J Cerni","year":"2023","unstructured":"Cerni J, Hosseinzadeh H, Mullan J, Westley-Wise V, Chantrill L, Barclay G, et al. Does geography play a role in the receipt of end-of-life care for advanced cancer patients? Evidence from an Australian local health district population-based study. J Palliat Med. 2023;26:1453. https:\/\/doi.org\/10.1089\/JPM.2022.0555.","journal-title":"J Palliat Med"},{"key":"1942_CR21","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/J.JPAINSYMMAN.2024.07.001","volume":"68","author":"A Anwar","year":"2024","unstructured":"Anwar A, Amin MK, Anwar S, Shahzad M. Bridge the gap: addressing rural End-of-Life care disparities and access to hospice services. J Pain Symptom Manage. 2024;68:e280\u20136. https:\/\/doi.org\/10.1016\/J.JPAINSYMMAN.2024.07.001.","journal-title":"J Pain Symptom Manage"},{"key":"1942_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/0269216314543042","volume":"29","author":"E Wilson","year":"2015","unstructured":"Wilson E, Morbey H, Brown J, Payne S, Seale C, Seymour J. Administering anticipatory medications in end-of-life care: a qualitative study of nursing practice in the community and in nursing homes. Palliat Med. 2015;29:60. https:\/\/doi.org\/10.1177\/0269216314543042.","journal-title":"Palliat Med"},{"key":"1942_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1472-684X-9-8","volume":"9","author":"D Bainbridge","year":"2010","unstructured":"Bainbridge D, Brazil K, Krueger P, Ploeg J, Taniguchi A. A proposed systems approach to the evaluation of integrated palliative care. BMC Palliat Care. 2010;9:8. https:\/\/doi.org\/10.1186\/1472-684X-9-8.","journal-title":"BMC Palliat Care"},{"key":"1942_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/HTA24250","volume":"24","author":"M Poolman","year":"2020","unstructured":"Poolman M, Roberts J, Wright S, Hendry A, Goulden N, Holmes EAF, et al. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT. Health Technol Assess. 2020;24:1\u2013149. https:\/\/doi.org\/10.3310\/HTA24250.","journal-title":"Health Technol Assess"},{"key":"1942_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.12968\/BJCN.2023.28.6.284","volume":"28","author":"L O\u2019Hara","year":"2023","unstructured":"O\u2019Hara L, Evans CJ, Bowers B. Family carers\u2019 administration of injectable medications at the end of life: a service evaluation of a novel intervention. Br J Community Nurs. 2023;28:284\u201392. https:\/\/doi.org\/10.12968\/BJCN.2023.28.6.284.","journal-title":"Br J Community Nurs"},{"key":"1942_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1017\/S1478951508000552","volume":"6","author":"BA Anderson","year":"2008","unstructured":"Anderson BA, Kralik D. Palliative care at home: carers and medication management. Palliat Support Care. 2008;6:349\u201356. https:\/\/doi.org\/10.1017\/S1478951508000552.","journal-title":"Palliat Support Care"},{"key":"1942_CR27","unstructured":"Poolman M, Shuler A. accessed May 12,. In the context of the national (Welsh) COVID-19 response POLICY AND PROCEDURE 2020. https:\/\/wales.pallcare.info\/index.php?p=sections&sid=11 (2025)."},{"key":"1942_CR28","doi-asserted-by":"publisher","unstructured":"Short C, Scott A. PA7 developing a culture of medication safety in the palliative care home setting - supporting choices in place of care and death. BMJ Support Palliat Care. 2015;5(Suppl 1). https:\/\/doi.org\/10.1136\/BMJSPCARE-2015-000906.67. :A21.3-A21.","DOI":"10.1136\/BMJSPCARE-2015-000906.67"},{"key":"1942_CR29","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1177\/0269216318773878","volume":"32","author":"S Healy","year":"2018","unstructured":"Healy S, Israel F, Charles M, Reymond L. Laycarers can confidently prepare and administer subcutaneous injections for palliative care patients at home: a randomized controlled trial. Palliat Med. 2018;32:1208. https:\/\/doi.org\/10.1177\/0269216318773878.","journal-title":"Palliat Med"},{"key":"1942_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/01621424.2022.2164539","volume":"42","author":"JA Pitts","year":"2023","unstructured":"Pitts JA, Geller G, Muller A. Caregiver experiences in administering subcutaneous medications to community palliative care patients: integrative review. Home Health Care Serv Q. 2023;42:154\u201372. https:\/\/doi.org\/10.1080\/01621424.2022.2164539.","journal-title":"Home Health Care Serv Q"},{"key":"1942_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/BMJSPCARE-2020-002394","volume":"10","author":"B Antunes","year":"2020","unstructured":"Antunes B, Bowers B, Winterburn I, Kelly MP, Brodrick R, Pollock K, et al. Anticipatory prescribing in community end-of-life care in the UK and Ireland during the COVID-19 pandemic: online survey. BMJ Support Palliat Care. 2020;10:343\u20139. https:\/\/doi.org\/10.1136\/BMJSPCARE-2020-002394.","journal-title":"BMJ Support Palliat Care"},{"key":"1942_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.12968\/IJPN.2016.22.8.369","volume":"22","author":"L Lee","year":"2016","unstructured":"Lee L, Howard K, Wilkinson L, Kern C, Hall S. Developing a policy to empower informal carers to administer subcutaneous medication in community palliative care; a feasibility project. Int J Palliat Nurs. 2016;22:369\u201378. https:\/\/doi.org\/10.12968\/IJPN.2016.22.8.369.","journal-title":"Int J Palliat Nurs"},{"key":"1942_CR33","doi-asserted-by":"publisher","first-page":"A47","DOI":"10.1136\/SPCARE-2021-PCC.125","volume":"11","author":"K Robinson","year":"2021","unstructured":"Robinson K, Mackie J, Keir NHS, Lothian S, Lewis M, Heneghan J, Burdon J. 107 A service evaluation of a new policy to support carers giving subcutaneous anticipatory medications at home at end of life within Southern Derbyshire, population of 607,000. BMJ Support Palliat Care. 2021;11:A47\u201347. https:\/\/doi.org\/10.1136\/SPCARE-2021-PCC.125.","journal-title":"BMJ Support Palliat Care"},{"key":"1942_CR34","unstructured":"NHS. Policy for Patient or Carer Administration of Subcutaneous Medication (Palliative Care). 2023. https:\/\/northyorkshireccg.nhs.uk\/wp-content\/uploads\/2021\/03\/HDFT-policy-for-patient-or-carer-adminstration-of-subcutaneous-medication-pa._.pdf (accessed May 12, 2025)."},{"key":"1942_CR35","unstructured":"NHS. Dorset Shared Care Protocol for informal carer administration of subcutaneous mediations for pain and symptom management in Community Palliative care 2020. https:\/\/nhsdorset.nhs.uk\/Downloads\/aboutus\/medicines-management\/Other%20Guidelines\/Protocol%20for%20carer%20sc%20admin%20-%20Apr%202020.pdf?boxtype=pdf&g=false&s=true&s2=false&r=wide (accessed May 12, 2025)."},{"key":"1942_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13063-019-3179-9\/TABLES\/2","volume":"20","author":"M Poolman","year":"2019","unstructured":"Poolman M, Roberts J, Byrne A, Perkins P, Hoare Z, Nelson A, et al. CARer-ADministration of as-needed subcutaneous medication for breakthrough symptoms in homebased dying patients (CARiAD): study protocol for a UK-based open randomised pilot trial. Trials. 2019;20:1\u201316. https:\/\/doi.org\/10.1186\/S13063-019-3179-9\/TABLES\/2.","journal-title":"Trials"},{"key":"1942_CR37","unstructured":"NIHR JLA. Palliative and end of life care n.d. https:\/\/www.jla.nihr.ac.uk\/priority-setting-partnerships\/palliative-and-end-of-life-care (accessed July 20, 2025)."},{"key":"1942_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17:1\u201313. https:\/\/doi.org\/10.1186\/S12913-017-2031-8.","journal-title":"BMC Health Serv Res"},{"key":"1942_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12913-022-07577-3\/TABLES\/2","volume":"22","author":"M Sekhon","year":"2022","unstructured":"Sekhon M, Cartwright M, Francis JJ. Development of a theory-informed questionnaire to assess the acceptability of healthcare interventions. BMC Health Serv Res. 2022;22:1\u201312. https:\/\/doi.org\/10.1186\/S12913-022-07577-3\/TABLES\/2.","journal-title":"BMC Health Serv Res"},{"key":"1942_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"key":"1942_CR41","unstructured":"NHS. What end of life care involves - NHS. 2022. https:\/\/www.nhs.uk\/tests-and-treatments\/end-of-life-care\/what-it-involves-and-when-it-starts\/ (accessed August 8, 2025)."},{"key":"1942_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough? Field Methods. 2006;18:59\u201382. https:\/\/doi.org\/10.1177\/1525822X05279903.","journal-title":"Field Methods"},{"key":"1942_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"key":"1942_CR44","unstructured":"Qualtrics. Qualtrics XM. Qualtrics. 2023. https:\/\/www.qualtrics.com."},{"key":"1942_CR45","unstructured":"Lumivero. NVivo. 2024. https:\/\/www.lumivero.com.."},{"key":"1942_CR46","doi-asserted-by":"publisher","DOI":"10.1177\/1609406917733847","author":"LS Nowell","year":"2017","unstructured":"Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017. https:\/\/doi.org\/10.1177\/1609406917733847.","journal-title":"Int J Qual Methods"},{"key":"1942_CR47","doi-asserted-by":"publisher","DOI":"10.5688\/AJPE7120","volume":"84","author":"JL Johnson","year":"2020","unstructured":"Johnson JL, Adkins D, Chauvin S. A review of the quality indicators of rigor in qualitative research. Am J Pharm Educ. 2020;84:7120. https:\/\/doi.org\/10.5688\/AJPE7120.","journal-title":"Am J Pharm Educ"},{"key":"1942_CR48","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/J.1365-2702.2008.02405.X","volume":"18","author":"PE Bee","year":"2009","unstructured":"Bee PE, Barnes P, Luker KA. A systematic review of informal caregivers\u2019 needs in providing home-based end-of-life care to people with cancer. J Clin Nurs. 2009;18:1379\u201393. https:\/\/doi.org\/10.1111\/J.1365-2702.2008.02405.X.","journal-title":"J Clin Nurs"},{"key":"1942_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/PON.3610","volume":"24","author":"P Hudson","year":"2014","unstructured":"Hudson P, Trauer T, Kelly B, O\u2019Connor M, Thomas K, Zordan R, et al. Reducing the psychological distress of family caregivers of home based palliative care patients: longer term effects from a randomised controlled trial. Psychooncology. 2014;24:19. https:\/\/doi.org\/10.1002\/PON.3610.","journal-title":"Psychooncology"},{"key":"1942_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007617.PUB2\/MEDIA\/CDSR\/CD007617\/IMAGE_N\/NCD007617-CMP-001-03.PNG","author":"B Candy","year":"2011","unstructured":"Candy B, Jones L, Drake R, Leurent B, King M. Interventions for supporting informal caregivers of patients in the terminal phase of a disease. Cochrane Database Syst Reviews. 2011. https:\/\/doi.org\/10.1002\/14651858.CD007617.PUB2\/MEDIA\/CDSR\/CD007617\/IMAGE_N\/NCD007617-CMP-001-03.PNG.","journal-title":"Cochrane Database Syst Reviews"},{"key":"1942_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0167204","author":"A Parand","year":"2016","unstructured":"Parand A, Garfield S, Vincent C, Franklin BD. Carers\u2019 medication administration errors in the domiciliary setting: a systematic review. PLoS One. 2016. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0167204.","journal-title":"PLoS One"},{"key":"1942_CR52","unstructured":"NHS England. Ambitions for Palliative and End of Life Care: A national framework for local action 2021\u20132026 2022. https:\/\/www.england.nhs.uk\/publication\/ambitions-for-palliative-and-end-of-life-care-a-national-framework-for-local-action-2021-2026\/. (accessed May 12, 2025)."},{"key":"1942_CR53","unstructured":"Finlay I, Richards M, Maskell R, Abrahams C, Brown M, Campbell et al. Palliative Care and End-of-Life Care: Opportunities for England (Volume 1), The Commission on Palliative and End-of-Life Care. 2025. https:\/\/img1.wsimg.com\/blobby\/go\/e5bbd9ef-01fd-45c0-b4f4-1cf6b62157b9\/VOLUME%201%20REPORT%20FINAL%20170625.pdf. (accessed May 12, 2025)."},{"key":"1942_CR54","unstructured":"Australian Government Department of Health and Aged Care. The National Palliative Care Strategy. 2018;2018. https:\/\/www.health.gov.au\/resources\/publications\/the-national-palliative-care-strategy-2018?language=en.\u00a0(accessed May 12, 2025)."},{"key":"1942_CR55","unstructured":"Canadian Partnership Against Cancer & Health Canada. The Canadian interdisciplinary palliative care competency framework A curriculum guide for educators and reference manual for disciplines providing palliative care. Toronto: 2021. https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2021\/07\/palliative-care-competency-framework-EN.pdf. (accessed May 12, 2025)."},{"key":"1942_CR56","unstructured":"The Guardian. Assisted dying set to become law in England and Wales after MPs pass bill 2025. https:\/\/www.theguardian.com\/society\/2025\/jun\/20\/assisted-dying-law-england-and-wales-bill-passed (accessed June 21, 2025)."},{"key":"1942_CR57","first-page":"6","volume":"56","author":"A Worth","year":"2006","unstructured":"Worth A, Boyd K, Kendall M, Heaney D, Macleod U, Cormie P, et al. Out-of-hours palliative care: a qualitative study of cancer patients, carers and professionals. Br J Gen Pract. 2006;56:6.","journal-title":"Br J Gen Pract"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-025-01942-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-025-01942-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-025-01942-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:47:07Z","timestamp":1767073627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12904-025-01942-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1942"],"URL":"https:\/\/doi.org\/10.1186\/s12904-025-01942-9","relation":{},"ISSN":["1472-684X"],"issn-type":[{"type":"electronic","value":"1472-684X"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received a favourable ethical opinion from the West of Scotland Research Ethics Committee 4, part of the UK Health Departments\u2019 Research Ethics Service (REC reference 24\/WS\/0026), for conduct in the NHS and private healthcare settings. The study also received regulatory approvals from the Health Research Authority (HRA) for sites in England, and from Health and Care Research Wales (HCRW) for sites in Wales. Informed consent was obtained from all study participants before any data collection. The research was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}